Citation Impact
Citing Papers
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
2001
Cellular and molecular mechanisms of fibrosis
2007 Standout
A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome
2011
Pathophysiological effects of aldosterone in cardiovascular tissues
2001
The Failing Heart — An Engine Out of Fuel
2007 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
The pathogenesis of cardiac fibrosis
2013 Standout
Prostacyclin protects against elevated blood pressure and cardiac fibrosis
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Induction of Cardiac Fibrosis by Aldosterone
2000
Chronic kidney disease
2011 Standout
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials
2002
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Cardiorenal Syndrome
2008 Standout
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Molecular Mechanisms of Myocardial Remodeling. The Role of Aldosterone
2002
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Myocardial Production of Aldosterone and Corticosterone in the Rat
1998
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene
2005 StandoutNobel
Effect of Spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
2000
The effects of spironolactone monotherapy on blood pressure and myocardial remodeling in spontaneously hypertensive rats: A stereological study
2003
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
2008 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disorders
2006
Selective Aldosterone Blockade Prevents Angiotensin II/Salt-Induced Vascular Inflammation in the Rat Heart
2002
Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice
2003
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Circulating Biomarkers in Patients with Heart Failure and Preserved Ejection Fraction
2013
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.
1994
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases
2003 Standout
Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction
1999
Contractile Systolic and Diastolic Dysfunction in Renin-Induced Hypertensive Cardiomyopathy
1997
Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats
2002
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice
2002 StandoutNobel
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Eplerenone
2003
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Modifications of myocardial Na+,K+-ATPase isoforms and Na+/Ca2+ exchanger in aldosterone/salt-induced hypertension in guinea pigs
1998
Relaxin Reverses Cardiac and Renal Fibrosis in Spontaneously Hypertensive Rats
2005 Standout
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Prostaglandins and Inflammation
2011 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction
2001
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial
2016
Works of V. Robert being referenced
In Vivo Left Ventricular Function and Collagen Expression in Aldosterone/Salt-Induced Hypertension
1998
Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation
1993
Different Regulation of Cardiac and Renal Corticosteroid Receptors in Aldosterone-salt Treated Rats: Effect of Hypertension and Glucocorticoids
2000
Relationship Between Sedentary Behavior and Cardiovascular Risk
2015
Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in Rats
1995